Pharmaceutical education for psychotic patients with physical complications

Utako Iwakiri, Junichi Senba, Keiji Suenaga, Takao Shimazoe

研究成果: Contribution to journalReview article査読

抄録

The mortality risk of metabolic disease for psychotic patients is reported to be high. Therefore, in this research, we investigated the compliance with drug therapy among psychotic patients who had diabetes or dyslipidemia. Based on this investigation, we counseled and educated the patients from the pharmaceutical point of view. The effects of pharmaceutical consultation and education were evaluated based on the compliance rate of drug therapy, body mass index (BMI), and blood glucose and cholesterol levels. A significant difference was found between the drug therapy compliance rate and blood glucose level after consultation and education. However, there was no significant difference in the BMI and blood cholesterol level. Our results suggest that patient education is effective in increasing the drug therapy compliance rate and reducing blood glucose levels in psychotic patients.

本文言語英語
ページ(範囲)493-496
ページ数4
ジャーナルYakugaku Zasshi
131
4
DOI
出版ステータス出版済み - 2011

All Science Journal Classification (ASJC) codes

  • 薬理学
  • 薬科学

フィンガープリント

「Pharmaceutical education for psychotic patients with physical complications」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル